SPIRO - CKD

• Research type

  Research Study

• Full title

  A Randomised Multicentre Open Label Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 3 Chronic Kidney Disease

• IRAS ID

  114759

• Contact name

  Jonathan Townend

• Contact email

  john.townend@uhb.nhs.uk

• Eudract number

  2013-002636-25

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  13/WM/0304

• Date of REC Opinion

  9 Sep 2013

• REC opinion

  Further Information Favourable Opinion